The tumor microenvironment (TME) consists of mediators surrounding a tumor, including diverse cell types, blood vessels, and ...

Ceralasertib in combination with Imfinzi (durvalumab) did not meet the primary endpoint of overall survival (OS) in the phase ...

Working the night shift, frequently flying across time zones or keeping an irregular sleep schedule does more than just leave ...

Cancer cells continuously interact with their surrounding microenvironment, critically influencing tumor development, metastasis, immune evasion, and therapy resistance. Metabolic reprogramming in ...

Metabolic reprogramming in the tumor microenvironment shapes immune function and therapy resistance, offering insights into ...

A review article led by researchers from the B·ARGO group at the Germans Trias i Pujol Research Institute (IGTP) and from the ...

The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid ...

The report is based on the experience of a patient with recurrent retroperitoneal DDLPS and is believed to be the first reported case in which such a patient achieved a pathological complete response ...

Chronic circadian disruption — such as night-shift work, irregular schedules, or frequent jet lag — accelerates the development and spread of aggressive breast cancer.

Pilatus Biosciences Announces FDA Clearance of IND Application for PLT012, a First-in-Class Anti-CD36 Metabolic Checkpoint ...

Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its ...